Aleix Prat Joins ONA Therapeutics at a Key Moment in Its Clinical Development / Aleix Prat, Beatriz Morancho Armisen, cancer ...
An AI-native pharmaceutical company launched with approximately $1 billion, integrating Protein Design and the Virtual Cell 'X-Cell'The reason for featuring Xaira Therapeutics in this 20-company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results